UnitedHealth Group Incorporated (UNH)
Why UnitedHealth Group (UNH) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
UnitedHealth: Patience Could Be Rewarded
UnitedHealth Group remains undervalued and is positioned as a strong long-term investment despite recent price appreciation and operational challenges. Management maintains a long-term growth algorithm of 13–16% bottom-line growth, driven by margin recovery, AI investments, and capital allocation including share buybacks. Current valuation models, even with conservative growth assumptions, suggest significant intrinsic value upside, but recent rapid price gains may limit short-term upside.
UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know
UnitedHealth (UNH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Up by 80%, does the UnitedHealth Group have more upside?
The UnitedHealth Group stock price has embarked on a major rally in the past few months and has recently formed the encouraging golden cross pattern. UNH jumped to $420, its highest level since April 25.
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
UnitedHealth Group (UNH) reached $427.89 at the closing of the latest trading day, reflecting a +2.97% change compared to its last close.
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
UnitedHealth Group (UNH) closed the most recent trading day at $415.53, moving +2.4% from the previous trading session.
Why UnitedHealth Group (UNH) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is UnitedHealth (UNH) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
UnitedHealth vs. Humana: Which Healthcare Leader Is a Better Bet Now?
UNH's diversified platform, AI investments and stronger earnings outlook give it an edge over Medicare-focused rival HUM.
Both Berkshire Hathaway and David Tepper Silently Dumped the Same Healthcare Giant in the Same Quarter
Warren Buffett's Berkshire Hathaway (NYSE:BRK.B | BRK.B Price Prediction) fully exited its UnitedHealth Group (NYSE:UNH) position in Q1 2026, and David Tepper's Appaloosa Management meaningfully reduced its UNH stake in the same quarter.
UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to UnitedHealth (UNH). This makes it worthwhile to examine what the stock has in store.
Here's Why UnitedHealth Group (UNH) Fell More Than Broader Market
In the latest trading session, UnitedHealth Group (UNH) closed at $399.53, marking a -1.99% move from the previous day.
